Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Circulating miRNAs as new activators of the JAK-STAT3 pathway.

Lam D, Barré B, Guette C, Coqueret O.

JAKSTAT. 2013 Jan 1;2(1):e22996. doi: 10.4161/jkst.22996.

2.

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.

Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, Ferrara N.

EMBO J. 2012 Aug 29;31(17):3513-23. doi: 10.1038/emboj.2012.183. Epub 2012 Jul 6.

4.

Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.

Ebong S, Chepelinsky AB, Robinson ML, Zhao H, Yu CR, Egwuagu CE.

Mol Vis. 2004 Feb 19;10:122-31.

5.

Activation of the Jak-STAT-signaling pathway in embryonic lens cells.

Potts JD, Kornacker S, Beebe DC.

Dev Biol. 1998 Dec 1;204(1):277-92.

8.

Human cytokines activate JAK-STAT signaling pathway in porcine ocular tissue.

Fasler-Kan E, Barteneva NS, Ketterer S, Wunderlich K, Reschner A, Nurzhanova A, Flammer J, Huwyler J, Meyer P.

Xenotransplantation. 2013 Nov-Dec;20(6):469-80. doi: 10.1111/xen.12070. Epub 2013 Nov 1.

9.

Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.

Omura T, Yoshiyama M, Ishikura F, Kobayashi H, Takeuchi K, Beppu S, Yoshikawa J.

J Mol Cell Cardiol. 2001 Feb;33(2):307-16.

PMID:
11162135
10.
11.

A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.

Kim BH, Yin CH, Guo Q, Bach EA, Lee H, Sandoval C, Jayabose S, Ulaczyk-Lesanko A, Hall DG, Baeg GH.

Mol Cancer Ther. 2008 Sep;7(9):2672-80. doi: 10.1158/1535-7163.MCT-08-0309.

12.
13.

Lipid-based carriers of microRNAs and intercellular communication.

Vickers KC, Remaley AT.

Curr Opin Lipidol. 2012 Apr;23(2):91-7. doi: 10.1097/MOL.0b013e328350a425. Review.

PMID:
22418571
14.

Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.

Liu J, Kern JA.

Am J Respir Cell Mol Biol. 2002 Sep;27(3):306-13.

PMID:
12204892
15.

[Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].

Espert L, Dusanter-Fourt I, Chelbi-Alix MK.

Bull Cancer. 2005 Oct;92(10):845-57. French.

16.

Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.

Kreis S, Munz GA, Haan S, Heinrich PC, Behrmann I.

Mol Cancer Res. 2007 Dec;5(12):1331-41. doi: 10.1158/1541-7786.MCR-07-0317.

17.

Constitutive activation of STAT transcription factors in acute myelogenous leukemia.

Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F.

Eur J Haematol. 2001 Aug;67(2):63-71.

PMID:
11722592
18.

Exosomes: Fit to deliver small RNA.

Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM.

Commun Integr Biol. 2010 Sep;3(5):447-50. doi: 10.4161/cib.3.5.12339.

19.

Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.

Pastuschek J, Poetzsch J, Morales-Prieto DM, Schleußner E, Markert UR, Georgiev G.

J Reprod Immunol. 2015 Apr;108:48-55. doi: 10.1016/j.jri.2015.03.002. Epub 2015 Mar 16.

PMID:
25817464
20.

The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.

Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M.

Oncogene. 2000 Sep 28;19(41):4795-801.

Supplemental Content

Support Center